{"filing":{"accession_number":"0001437749-26-020384","cik":"0000925741","ticker":"BCDA","company_name":"BioCardia, Inc.","form":"8-K","filing_date":"2026-06-12","report_date":null,"primary_document":"bcda20260612_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/925741/000143774926020384/bcda20260612_8k.htm"},"events":[{"id":10399,"run_id":9121,"accession_number":"0001437749-26-020384","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"BioCardia received a Nasdaq delisting notice on April 10, 2026 for failing to maintain the $2.5 million minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1). Although the company claims to have regained compliance through an ATM offering that raised $4.9 million in net proceeds, Nasdaq retains ongoing monitoring authority and explicitly warns that \"if at the time of its next periodic report the Company does not evidence compliance, it may be subject to delisting.\" This is a classic delisting-risk disclosure under Item 3.01.","company_name":"BioCardia, Inc.","ticker":"BCDA","filing_date":"2026-06-12","submitted_at":null,"items":[{"id":6705,"accession_number":"0001437749-26-020384","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"BioCardia received a Nasdaq delisting notice on April 10, 2026 for failing to maintain the $2.5 million minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1). Although the company claims to have regained compliance through an ATM offering that raised $4.9 million in net proceeds, Nasdaq retains ongoing monitoring authority and explicitly warns that \"if at the time of its next periodic report the Company does not evidence compliance, it may be subject to delisting.\" This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:19:05.214165+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6705,"accession_number":"0001437749-26-020384","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"BioCardia received a Nasdaq delisting notice on April 10, 2026 for failing to maintain the $2.5 million minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1). Although the company claims to have regained compliance through an ATM offering that raised $4.9 million in net proceeds, Nasdaq retains ongoing monitoring authority and explicitly warns that \"if at the time of its next periodic report the Company does not evidence compliance, it may be subject to delisting.\" This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:19:05.214165+00:00","company_name":"BioCardia, Inc.","ticker":"BCDA","filing_date":"2026-06-12"}]}